According to the Zhitong Finance App, China Biopharmaceutical (01177) announced that on October 13, 2026, the company spent HK$395.648 million to repurchase 7.4 million shares at a repurchase price of HK$5.325-5.35 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.